(Q45077713)

9 December 2017

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial (English)

1 reference

9 December 2017

0 references

1 reference

1 reference

Morris Maizels

1

1 reference

PubMed ID

15447697

9 December 2017

Andrew Blumenfeld

series ordinal

2

1 reference

PubMed ID

15447697

9 December 2017

Raoul Burchette

series ordinal

3

1 reference

9 December 2017

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

44

1 reference

9 December 2017

9

1 reference

9 December 2017

885-890

1 reference

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04170.X

Feverfew as a preventive treatment for migraine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04170.X

A quantification of the placebo response in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04170.X

MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04170.X

10.1111/J.1526-4610.2004.04170.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15447697